From October 2022, the work of the NABCOP has been expanded on by two new national audits of primary breast cancer and metastatic breast cancer in women and men of all ages.

Find out more.

Adjuvant chemotherapy & trastuzumab for HER2-positive early invasive breast cancer

Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England

Melissa Ruth Gannon, David Dodwell, Yasmin Jauhari, Kieran Horgan, Karen Clements, Jibby Medina, David Alan Cromwell

Published online: January 29, 2020. Journal of Geriatric Oncology

View the Journal